glp 1 agonists and anesthesia New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review New Study Recommends Stopping GLP-1
Description
When researchers look beyond it - at the immune system, the brain, and the reproductive system - a different picture begins to emerge
The medical director of the VCU Health Medical Weight Loss Program explains what these medications do to the body and why they might not be suited for everyone
This approach can help maintain steady energy levels and makes adequate nutrition more achievable when appetite is reduced
L.et al (2021)
2024;16(8):e66500
Hwang, E
